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Abstract
Background: Gametocytes are the sexual form of the malaria parasite and the main agents of transmission. While
there are several factors that influence host infectivity, the density of gametocytes appears to be the best single
measure that is related to the human host’s infectivity to mosquitoes. Despite the obviously important role that
gametocytes play in the transmission of malaria and spread of anti-malarial resistance, it is common to estimate
gametocyte carriage indirectly based on asexual parasite measurements. The objective of this research was to
directly model observed gametocyte densities over time, during the primary infection.
Methods: Of 447 patients enrolled in sulphadoxine-pyrimethamine therapeutic efficacy studies in South Africa and
Mozambique, a subset of 103 patients who had no gametocytes pre-treatment and who had at least three non-
zero gametocyte densities over the 42-day follow up period were included in this analysis.
Results: A variety of different functions were examined. A modified version of the critical exponential function was
selected for the final model given its robustness across different datasets and its flexibility in assuming a variety of
different shapes. Age, site, initial asexual parasite density (logged to the base 10), and an empirical patient category
were the co-variates that were found to improve the model.
Conclusions: A population nonlinear modeling approach seems promising and produced a flexible function
whose estimates were stable across various different datasets. Surprisingly, dihydrofolate reductase and
dihydropteroate synthetase mutation prevalence did not enter the model. This is probably related to a lack of
power (quintuple mutations n = 12), and informative censoring; treatment failures were withdrawn from the study
and given rescue treatment, usually prior to completion of follow up.
Background
Gametocytes are the sexual form of the malaria parasite
and the main agents of transmission. Malaria is diag-
nosed based on the presence of asexual parasites and
most anti-malarials act on these stages with the aim of
eliminating them. However, of vital importance to con-
trol (and eventually eliminate) malaria and prevent the
spread of drug resistance is the prevention and/or cur-
tailment of gametocytemia [1,2].
While transmission of the malaria parasite is dependent
on various factors such as vector characteristics, host sus-
ceptibility and climatic conditions, it is host infectivity
(the probability of a mosquito becoming infected after
biting an infected person) that plays a crucial role in the
onward spread of an individual infection [3-5]. There are
various factors that influence human host infectivity to
mosquitoes and the density of gametocytes appears to be
the best single measure available [3].
Despite the obvious importance of gametocyte carriage
for both the transmission of malaria and the spread of
resistance, little research has been conducted modeling
gametocyte densities, and by extension host infectivity,
directly. Rather, models generally rely on the more fre-
quently measured asexual parasite densities from which
gametocyte carriage is estimated by either making a
simple assumption (such as a constant gametocyte
switching rate), or by using a more advanced model
such as using lagged values based on asexual parasite
densities [6,7].
Yet the relationship between gametocytes and asexual
parasites is not straightforward. While one would expect
a higher asexual parasite load to be associated with a
higher sexual parasite load, there are also other factors
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as immunity, treatment or a long duration of infection.
As some of these factors would also increase gametocyte
carriage, the relationship in question is often con-
founded in a clinical setting [2,8].
The primary objective of this research was therefore to
model gametocytes directly to produce gametocyte den-
sity curves over time for various patient profiles. These
curves could then be used to estimate gametocyte densi-
ties and clearance rates, hence leading to a more realis-
tic understanding of infectivity in the population.
Distributions of gametocytemia have interesting features
that need to be addressed as part of any statistical analy-
sis or modeling. These include:
(i) Repeated measures: Patients are seen on up to
nine occasions during a 42-day period and gameto-
cyte densities are measured on seven of these
occasions.
(ii) Study design: Studies are designed to monitor
asexual parasite density as an indicator of therapeu-
tic efficacy. Gametocyte emergence lags asexual
parasite emergence and hence the intervals for mea-
surement of gametocytemia are not ideal.
(iii) Informative censoring for treatment failures:
Patients are withdrawn and given rescue treatment if
parasites do not clear or if they re-emerge, resulting
in censoring of gametocyte distributions. In this way
the failure to clear asexual parasites is a competing
event to the measuring of gametocytes, with the
result that the gametocyte distributions are not seen
or are incomplete for patients who are resistant to
the anti-malarial being studied and hence are with-
drawn due to treatment failure.
One way of dealing with the bias due to informative
censoring is, or could be, by imputation of the missing
parts of the gametocyte distributions. To do this, a
method that directly models the gametocyte density-time
relationship for different groups of patients is needed.
Methods
Patient Data
Data for this research came from open label clinical
trials of patients treated with sulphadoxine-pyrimetha-
mine (SP) for uncomplicated symptomatic falciparum
malaria at the Naas and Mangweni clinics (Mpumalanga
province, South Africa) and Namaacha and Bela Vista
Clinics (Maputo province, Mozambique). The study
design focused on measuring the clinical and asexual
parasitological response to treatment as recommended
by the World Health Organization. Gametocyte densities
were thus measured on days 0, 3, 7, 14, 21, 28, and 42
following treatment.
Of the 447 patients enrolled in these studies [9-11], a
subset of 103 patients who had no gametocytes pre-
treatment and who had at least three non-zero gameto-
cyte density measurements (including 56 patients with
at least four non-zero readings) were included in this
analysis. Patients with gametocytes pre-treatment (n =
23) were excluded so that the analysis could focus on
the development of gametocytes during the primary
infection, rather than pre-existing gametocytes poten-
tially from previous infections. Gametocyte density was
counted on thick blood smears against 1,000 leukocytes
assuming 8,000 leukocytes per microlitre (μL). This
explains why the lowest detectable density was 8 per μL
as the smallest possible count would have been one
gametocyte per 1,000 leukocytes.
Patients who failed treatment (in that they failed to
clear their asexual parasites) were withdrawn from the
study to be given rescue treatment and effectively were
lost to follow up. Due to the time lag between asexual
parasites and sexual gametocytes, the distribution of
gametocyte densities for these patients were often trun-
cated or, in some cases, the patients were withdrawn
prior to the emergence of gametocytes. This resulted in
informative censoring of gametocyte density distribu-
tions for treatment failures.
The original gametocyte readings were logged to the
base two for the modeling. It is common to log a mea-
surement that is characterized by long right tails and
where it is more meaningful to express increases in a
multiplicative rather than additive manner. Using a loga-
rithmic scale with base two allowed a one unit change
i nt h er e s p o n s et ob ev i e w e da sad o u b l i n go rh a l v i n g .
For example, the gametocyte elimination half-life is the
time it takes for the density of gametocytes to halve.
The main problem with the data was the high preva-
lence of zero measurements and their associated uncer-
tainty. Attempting to include many zeros in the data
when trying to solve nonlinear mixed effect models led
to estimation difficulties. Therefore there were two broad
treatments of these zeros. In both cases the zero reading
at day 0 was left at zero and patients exhibiting gameto-
cytes on day 0 were excluded. In the first dataset (here-
after referred to as Data 1) all subsequent zeros were put
to missing, while in the second instance (Data 2)t h e y
were changed to the detectable limit of eight gametocytes
per microlitre (μL). Histograms were examined showing
the overall frequency distributions and found that the
shape of the distribution does not change qualitatively
when we change the eight to a four or a twelve.
Ethical considerations
These studies were approved by the Research and Ethics
Committees of the University of Cape Town, the Mpu-
malanga Department of Health and the Mozambican
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cal studies were conducted in accordance with the
South African Clinical Trials Guidelines [12] and the
principles laid down by the World Health Assembly of
1975 on Ethics in Human Experimentation and the Hel-
sinki Declaration. Written Informed consent was
obtained from each subject or their guardian. In the
case of illiteracy, an “X” mark was accepted as docu-
mentation of consent in the presence of an independent
literate witness who also signed the consent form. Study
subject identities were kept confidential. Those who
chose not to participate in this study were treated with
sulphadoxine-pyrimethamine but without routine follow
up. At the time of the study, sulphadoxine-pyrimetha-
mine and chloroquine monotherapies were the malaria
treatment policies in Mpumalanga Province, South
Africa and Mozambique, respectively.
Empirical patient categories
Broadly speaking, three different patterns in the
untransformed response were apparent across the sam-
ple of patients (see Figure 1). The grouping of patients
was therefore an empirical exercise and the categories
were created as follows:
Figure 1 Typical curves for the different patient categories. Displays typical curves for the three empirically created patient categories.
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included patients that experienced an initial increase fol-
lowed by a decrease that did not increase again.
group 2: the second group was for patients who
experienced a second increase in gametocytes after the
initial rise had started going down but the increase was
slight i.e. less than a twofold increase.
group 3: the third category included those patients that
experienced a marked second increase in gametocytes
after the initial rise had started going down. The marked
increase was defined as a change of at least twofold.
The three empirically created patient categories for the
103 patients included in the modeling were compared
with regards to demographic and diagnostic variables in
an attempt to see whether they could be explained by
patient-specific features. Fisher’sE x a c tt e s tw a su s e dt o
assess dependence between the categorical variables due
to small numbers in the cells, and the Kruskal-Wallis test
was used to test for differences in continuous variables
across groups given the skew distributions. The results are
summarized in Table 1. The three empirically created
patient groups did not clearly correspond to specific
patient profiles as measured by the demographic and dis-
ease-specific co-variates. These groupings are most likely
to reflect the effect of characteristics not documented in
this study (e.g. delay in seeking treatment, degree of syn-
chronicity, level of immunity).
Statistical Analysis
The gametocyte density-time profiles were typically non-
linear and were further characterized by both intra-indi-
vidual variability due to repeated measures and inter-
individual variability, which made nonlinear mixed
effects modeling the appropriate statistical methodology.
The modeling was conducted using R 2.2.0 [13] and in
particular the nlme package [14].
Nonlinear mixed effects modeling is generally done in
two stages:
1. Finding an underlying (nonlinear) function with a
common structure that could be generating the data:
yij = f (tij, bi)+eij where yij is the observed response
for the ith subject at the jth time point, f (tij, bi)
refers to a function f whose structure is common to
all patients with tij representing time and parameters
bi representing the value for the function’s para-
meter(s) for the ith person, and eij refers to the error
or residual for the ith person at the jth time point
and eij ~ N (0, Vi)w i t hVi being the intra-individual
covariance matrix.
2. Inter-individual variability is modeled by adding ran-
dom effects to mean parameters to allow individual
specific responses, bi = b + bi where bi is subject i’s
parameter value for the function and can be thought
of as some random deviation (bi also know as a ran-
d o me f f e c t )f r o mt h em e a np a r a m e t e rv a l u e( b). It is
assumed that bi ~ N (0, D) where D is a (k × k)d i s p e r -
sion matrix for the k random effects, and that the bi
are independent of each other and the eij.
Co-variates can also be used to explain systematic
variability in the actual parameter values between sub-
jects: bi = Ab + bi where the matrix A is a design matrix
formed from one or more co-variates.
Table 1 Univariate analysis of determinants of patient category.
Variable Patient Category Pvalue Test
1 (n = 74) 2 (n = 14) 3 (n = 15)
Mutation Sensitive 60 (73%) 9 (11%) 13 (16%) 1
Resistant 7 (64%) 3 (27%) 1 (9%) 0.30
Treatment Success 66 (71%) 14 (15%) 13 (14%)
Outcome Failure 7 (78%) 0 (0%) 2 (22%) 0.47
Site Mpumulanga 50 (69%) 10 (14%) 12 (17%)
Maputo 24 (77%) 4 (13%) 3 (10%) 0.70
Gender Male 35 (70%) 7 (14%) 8 (16%)
Female 39 (74%) 7 (13%) 7 (13%) 0.95
Parasite Clearance Time Median 3 2 3 0.38 2
IQ Range 2-3 2-7 3-7
Age Median 18 11 20
IQ Range 10-29 9-14 12-50 0.09
Logged Parasite Density Mean 4.5 4.5 4.6
Std Dev 0.5 0.5 0.5 0.37
Summarises the results from exploring associations with patient category.
1 = Fisher’s Exact test; 2 = Kruskal Wallis test.
The percentages shown are row percentages.
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is placed not on the actual value of the random effects
(bi’s) but rather the size of their variability. The covar-
iance matrix of the random effects is specified with the
model and includes both diagonal elements (variances of
the random effects for particular parameters) and off-
diagonal elements (covariance of the random effects
between different parameters). More complicated struc-
tures are obviously more difficult to solve.
Various subsets of the data were modeled (not all
shown here) and these models were compared by look-
ing at both the Akaike Information Criteria’s( A I C ’s),
and at how robust the functions were across different
datasets. The AIC is the appropriate statistic for com-
paring different models fitted by maximum likelihood.
The aim was to find a function that fitted the data well,
that made biological sense, and that was not overly sen-
sitive to either the treatment of the zeros or the inclu-
sion of different patient categories.
Finding the function
In total six different nonlinear functions were initially
fitted to the different datasets. These functions included
classic pharmacokinetic fun c t i o n ss u c ha st h eo n ea n d
two compartment models, the critical exponential (a
variation of the double exponential), a reduced form of
the critical exponential (hereafter called the “modified
critical exponential”), and wave-like functions, such as
the fourier and double fourier. Models based on differ-
ent nonlinear functions were compared using the AIC
statistic. Mixed effect modeling started with the most
general and complex variance-covariance structure i.e.
random effects for all function parameters were
included and nonzero correlations amongst all of them
were allowed. If this complex structure could be esti-
mated, the results were examined for signs of possible
improvement/simplification, i.e. non-significant and/or
unnecessary random effects were dropped. If the model
with the most general variance-covariance structure
could not be estimated, a simpler structure was
attempted. The resulting nested models were compared
using likelihood ratio (LR) c
2 statistics.
Use of the LR test in this strategy meant that Maxi-
mum Likelihood (ML) was used as opposed to
Restricted Maximum Likelihood (REML) in the estima-
tion process; any change to either the fixed or the ran-
dom effects structure affected the REML likelihood and
hence different structures could not be compared in this
way if REML was used.
Adding co-variates
This phase examined if any co-variates could improve
the model and explain some of the individual variation
in the model parameters, thereby reducing the random
effects. As suggested by Pinheiro and Bates [15], the
strategy was to fit a model without any co-variates and
then plot the random effects from this model against
the potential co-variates. Any systematic pattern in the
relationship between a potential co-variate and a parti-
cular random effect suggested that the particular co-
variate be included in the model. Co-variates were
added to the model one at a time starting with the one
with the most obvious pattern. The new model was
fitted and the process repeated with the new set of ran-
dom effects. In addition to the LR test for nested mod-
els, statistical significance of any fixed effect associated
with a co-variate was examined and various interactions
were also explored.
The prospectively defined co-variates used in this ana-
lysis included: site (Mpumulanga vs Maputo province as
the reference), age in years, gender (males versus
females), day 0 parasite density (logged to the base 10),
mutations associated with SP resistance (quintuple ver-
sus 0-4 mutations) [16], treatment outcome (failure ver-
sus success), parasite clearance time (either 1, 2, 3 or 7
days), and the empirical patient category described
above.
Results and Discussion
Final function
Only the results from the two exponential functions as
well as from the one-compartment model are presented
along with AIC’s for the two datasets (see Table 2). One
of the salient features that emerged from the model-fit-
ting was that the critical exponential function was
clearly over-parameterized: in many of the models fitted
neither the A nor the B parameter was significant. This
was hardly surprising when considering the fact that
Eastwood et al [17] used the critical exponential func-
tion to model gene expressions over time and referred
to the A parameter as indicating the asymptotic
response level, and the A+B parameter as determining
the response at time = 0 (while the C and R parameters
determined the shape of the curve). Since gametocyte
density profiles needed to begin at zero and eventually
clear i.e. end at zero, the A and B parameters should be
Table 2 Comparison of Models.
Function Form* AIC
Data 1 Data 2
One
Compartment


0
12 
  ()
() () exp exp
tt 1600 3008
Critical
exponential
A +( B + C × t)×R
t) 1772 2877
Modified
critical
exponential
(C × t)×( R
t) 1869 2776
Compares the fit from the one compartment, critical exponential and the
modified critical exponential functions.
* Note that t refers to time whereas bi, A, B, C and R refer to function
parameters.
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cal exponential” function.
I tw a sa p p a r e n tt h a tt h eA I Cf r o mt h eo n ec o m p a r t -
ment model was better than the other two functions for
Data 1, but unfortunately the one compartment model
did not perform well with Data 2. In Data 1 the zeros
were dropped thereby allowing a smoother function to
be fitted as the fitted curve did not need to reach down
to the extremely small observations later on. When the
zeros were replaced by a small number (in this case 8)
in Data 2, the function then attempted to take these
dips into account.
Figure 2 shows the fitted curves for a particular
patient for the one compartment model, the critical
exponential and the modified critical exponential func-
tion applied to both datasets. The three points on the
same horizontal band in the right hand panel refers to
the three zeros for this patient that were ignored in the
1st dataset but were now assumed to be eight gameto-
cytes μL. This figure clearly shows how using the one
Figure 2 Comparing different functions according to treatment of zeros. Displays the fitted curves for a particular patient for the one
compartment model, the critical exponential and the modified critical exponential function applied to both datasets.
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right-hand tail that corresponded to a very slow elimina-
tion of gametocytes that did not appear to be biologi-
cally plausible. Therefore, the one compartment model
could not have been chosen despite having lower AIC’s
for the models fitted to Data 1, and Data 2 was consid-
ered a preferable treatment of the zeros.
The results from fitting the two exponential functions
to the two datasets are summarized in Table 3. Note
that a random effect between two parameters refers to
the correlation between those two random effects (e.g.
rCR), whereas a random effect for a single parameter is
expressed as a standard deviation (e.g. sC).
For the critical exponential function fitted to Data 1,
the estimated A and B parameters cancelled each other
out and the lack of a zero or near to zero reading at the
last time point resulted in a biologically implausible
asymptotic level of approximately 5 (or 2
5 =3 2μL). For
Data 2, both the A and B parameters were estimated to
be essentially (or close to) zero.
The modified critical exponential function (where the
A and B parameters were fixed to zero) was the final
function chosen as most appropriate for this data. This
decision was based on the clear stability that this struc-
ture demonstrated across various datasets (including a
subset of patients that had at least four non-zero game-
tocyte density readings), particularly with regards to the
parameter R. It is worth noting that the chosen function
has only two fixed effect parameters and that the data
did not seem able to support more complicated func-
tions. For Data 2, fixing the A and B parameters to
equal zero enabled us to estimate random effect compo-
nents for the R parameter, and resulted in a better fit-
ting model (AIC = 2776 vs 2877).
The modified critical exponential function is similar to
an ordinary exponential decay curve ye x p
t 
 

0
1 *
() .
This is apparent when it is rewritten as y =( C*t )×exp
(logRt) where logR can be substituted for -b1, thereby con-
straining R to fall between zero and one in order to give
a negative value. The difference is that the first term
(C*t ) is not constant like b0 but rather depends on
time. The ordinary exponential decay curve has the
property that the ratio of the response at successive
time points (
ft
ft
()
()
1 ) is equal across the range of the
function. This property does not hold for the modified
critical exponential function.
The modified critical exponential function was
explored further by examining the relative contributions
of the two terms in the function (plotted in Figure 3).
Note that the second term was plotted against the Y
axis on the right that was on a different scale to the Y
axis on the left. The first term (C*t ) increased linearly
with t. The contribution of the second term (exp
logRt)
was to exponentially decay the linearly increasing
amount from the first term, with higher values for R
leading to a slower rate of decay. The fact that term one
increases with X is what differentiates this function
from an ordinary exponential decay curve and allows
the function to increase initially, provided C is estimated
to be positive.
Final model
The second stage of modeling resulted in the co-variates
age, site (Mpumulanga vs Maputo province), logged
baseline parasite density, and empirical patient category
(pcat) being included in the model. The final model for-
mulation was thus as follows:
The first stage (within-subject) of the model for indivi-
dual i at time j:
yC tRe ij i ij i
t
ij
ij  (*) * ( )
and: eij ~ N (0, Vi)
and the second stage of the model could be written as:
Cc
R
iC C iC iC i i
iR R i
   
 
  

01 2 3
01
23 ** *
*
site pcat pcat
site     Ri R i R i R i i
ii
r
cr
23 4 5 23 ** * *
,~
age logpdens pcat pcat
and 
  
N ND (, ) 0
w h e r es i t ec o m p a r e dM p u m u l a n g ap r o v i n c et o
Maputo province and pcat 2 and pcat 3 were two
dummy variables for the patient category variable that
used the first category as the reference category. Para-
meter estimates (along with 95% confidence intervals)
are given in Table 4.
The effects of the co-variates were visually explored by
examining curves generated from the final model and
are summarized briefly here. The effects of the
Table 3 Critical exponential model & modified version.
Model Fixed Effects (std error) Random Effects
ABCR sC sR rCR AIC
Critical Exponential Data 1 5.04 (0.239) -4.90 (0.274) 1.96 (0.059) 0.88 (0.005) N/A 0.025 N/A 1772
Data 2 0.04 (0.577) 0.19 (0.620) 1.54 (0.056) 0.93 (0.003) 0.33 N/A N/A 2877
Modified version Data 1 Fixed at 0 Fixed at 0 1.86 (0.072) 0.93 (0.002) 0.64 0.016 -0.79 1869
Data 2 Fixed at 0 Fixed at 0 1.68 (0.064) 0.93 (0.002) 0.57 0.015 -0.77 2776
Summarises the results from fitting the two exponential functions.
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ure 5 (for median age and baseline parasite density).
Patients from Mpumulanga tended to reach lower
gametocyte densities compared to patients from Maputo
and had slower rates of clearance (as indicated by a
negative value for bC1 and a positive value for bR1, while
older people and people with high pre-treatment asexual
parasite densities tended to have higher gametocyte den-
sities (Table 4 shows that the R parameter varied
according to age and baseline parasite density level).
The site effect could reflect the level of immunity as
malaria transmission in Maputo, Mozambique is much
more intense (> 20-fold higher prevalence) than in
Mpumulanga, South Africa - and delayed treatment
seeking in partially immune patients may explain the
faster increase as well as the faster clearance rate seen
in Mozambique. The site effect could also reflect other
unmeasured characteristics such as genetic differences.
Since 1900 it has been recognized that the frequency
and density of asexual parasites decreases with increas-
ing age in areas with stable malaria transmission as a
result of partial immunity being acquired [6,18].
Figure 3 Exploring the modified critical exponential curve. Examines the relative contributions of the two terms in the modified critical
exponential function.
Table 4 The Final Model.
Parameters Final
Model
(95% CI)
Fixed Effects C Intercept (bC0) 2.1077 (1.8851 : 2.3303)
Mpm vs Map
(bC1)
-0.4988 (-0.7503 : -0.2472)
Pcat2 vs 1 (bC2) -0.0590 (-0.3810 : 0.2630)
Pcat3 vs 1 (bC3) -0.4910 (-0.7989 : -0.1832)
R Intercept (bR0) 0.8846 (0.8685 : 0.9007)
Mpm vs Map
(bR1)
0.0153 (0.0093 : 0.0213)
Age (years) (bR2) 0.0002 (0.0001 : 0.0003)
log10 (pdens)
(bR3)
0.0061 (0.0027 : 0.0095)
Pcat2 vs 1 (bR4) 0.0106 (0.0032 : 0.0179)
Pcat3 vs 1 (bR5) 0.0134 (0.0058 : 0.0210)
Random
Effects
sC 0.4854 (0.3964 : 0.5944)
sR 0.0101 (0.0078 : 0.0130)
rCR -0.7447 (-0.8479 : -0.5872)
Whole model AIC 2727.1 NA
Log Lk -1349.5 NA
Residual error 1.3703 (1.2864 : 1.4597)
Summarises the results (with confidence intervals) from the final model.
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nity, so age is often used as a proxy to measure the
effect of acquired immunity on various clinical and
parasitological outcomes (asexual parasite density, fail-
ure rates, severe malaria rates) [6,19]. As immunity
increases with age in areas of stable malaria transmis-
sion, lower immunity in children would result in chil-
dren seeking treatment earlier than adults, explaining
the slightly higher gametocyte densities in adults. As
expected, higher asexual parasite densities at baseline
were related to higher gametocyte densities.
Lastly, the model predicted that patients in category
two, on average, had a higher and later peak than cate-
gory one but with a very similar rate of increase and
decrease. On the other hand, the model predicted that
patients in the third category had a lower peak that
occurred slightly later and then cleared more slowly, i.e.
these patients would have carried gametocytes for
longer. This made sense when one considered that
patients in the third category had a second (and some-
times third) wave of gametocytes, and that the function
used in the model coped with this by smoothing out
Figure 4 Site effect. Curves generated from the model that
illustrate the site effect.
Figure 5 Patient category effect. Curves generated from the model that illustrate the patient category effect.
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and a slower clearance rate.
It was interesting that there was very little difference in
the effect of the other co-variate parameters when exclud-
ing patient category. This suggested that the patient cate-
gories could be viewed as a proxy for characteristics that
were not measured (ie immunity, duration of primary
infection and degree of synchronicity), yet were also inde-
pendent from the available co-variate information.
Model fit
The adequacy and validity of the fitted models were
assessed using an analysis of residuals that confirmed
that all assumptions regarding normality and constant
variance were met. Figure 6 compares fitted lines to
observed profiles for a subset of patients. The chosen
function appeared to be capable of taking on a wide
array of shapes with just two parameters. These plots
show that the population curves in general approxi-
mated the observed data fairly well and that adding ran-
dom effects improved the fit for the different
individuals.
Conclusions
Host infectivity is a critical component in the transmis-
sion of malaria and the spread of anti-malarial drug
resistance. While various factors are thought to influ-
ence host infectivity, the best indicator appears to be
gametocyte density. The huge obstacle that drug resis-
tance poses for the control of malaria together with the
role that gametocytes play in the spread of such resis-
tance makes it critical to examine gametocyte carriage
more closely.
However, most malaria transmission models are based
on asexual parasite distributions that infer gametocyte
densities through assumed switching rates. Yet the rela-
tionship between asexual and sexual parasites is com-
plex and so models that can cope with modeling
gametocyte data directly are desirable. The model devel-
oped in this research aimed to make a contribution by
modeling gametocytes directly. The study design from
which this data was obtained (which is used for most
clinical trials) used measurement points that were based
around the expected clinical and asexual parasitological
response to malaria treatment, and hence patients were
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Page 10 of 12seen fairly intensively during the first week of their
infection and then less intensively later on, i.e. a gap of
14 days between the last two time points. Since the dis-
tribution of gametocytes lags that of asexual parasites
the current design was not optimal for measuring game-
tocytes and consequently non-zero gametocyte densities
were relatively sparse. This problem was exacerbated by
the withdrawal of patients who failed treatment so that
they could be given rescue treatment.
From a public health perspective, accurately describing
gametocyte carriage (and hence infectivity) is of greater
relevance at the population level than for individual
patients and hence a population modeling approach was
used to overcome the limitations of sparse data. The
model developed with the modified critical exponential
function seems able to encompass a wide range of varia-
bility in the curves, and appeared to be stable across the
different datasets. The main use of the derived model
would be to simulate curves that could be used to
impute truncated/censored gametocyte distributions
possibly using a multiple imputation method http://
www.missingdata.org.uk.
The spread of resistant infections results from their
increased gametocytaemia [16]. Thus it was surprising
that the resistant (quintuple) mutation variables did not
enter the model. This may be related to power as there
were very few patients (n = 12) included with highly
resistant infections. Including those patients with game-
toytes pre-treatment (many of which would be recrudes-
cent infections) would improve power, as these patients
had a greater tendency to carry the quintuple mutation
[8/23 (35%) vs 12/103 (12%), pvalue = 0.001], though as
stated above the objective was to model gametocyte den-
sities during the primary infection. Furthermore, most
treatment failures were rescued and withdrawn from the
study prior to completion of follow up. This informative
censoring makes it very difficult to accurately estimate
these gametocyte density-time profiles in resistant infec-
tions. Either a questionable assumption (such as equating
their curves to those cured) has to be made, or a different
study design that monitors gametocytes after patients
have been withdrawn is needed. The issue of informative
censoring in gametocyte data is an avenue that needs to
be explored further. More data containing patients with
resistant infections would increase the power to detect a
“mutation effect” and hence allow the estimation of
curves for treatment failures.
Lastly, this research was limited to carriers of gameto-
cytes. In order to model the dynamics of malaria trans-
mission and the spread of resistance in a population, the
determinants of gametocyte prevalence should be
assessed as reported previously using zero-inflated mod-
els used by Barnes et al [16,20].
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